U.S. patents available from 1976 to present.
U.S. patent applications available from 2005 to present.

Icon_funbox Quotables

"Fooling around with alternating current is just a waste of time. Nobody will use it, ever."

Thomas Edison ; 1889

Newsletter  PatentStorm News

Make the Most of Our Site

See this month's Top Inventors and Most Cited Patents.

Stay on top of the latest innovations by subscribing to an RSS feed.

Registered users: Manage your profile.

 

Class 544/104 - Sulfur containing


Subclass of Class 544 - Organic compounds -- part of the class 532-570 series
Definition: Compounds which include sulfur.
No. of patents: 42
Last issue date: 09/18/2007


1    
NumberTitleIssue Date
7270857Liquid crystal composition and liquid crystal element
The present invention relates to a liquid crystal composition comprising a compound represented by the following formula (1) and a liquid crystal and a liquid crystal element containing the liquid crystal composition: ...
09/18/2007
7041821Synthetic molecules for labeling histidine-rich proteins
The invention provides Zn-chelating compounds that are molecularly engineered to bind to a specific target sequence in a protein of interest. The Zn2+ ion is far less toxic and promiscuous than nickel and therefore provides an attractive alternative to Ni...
05/09/2006
6992092Anti-diabetic agents
The present invention provides compounds of formula (I) the stereoisomers and prodrugs thereof, and the pharmaceutically acceptable salts of the compounds, stereoisomers, and prodrugs; wherein R1, R2
01/31/2006
6933384Synthetic molecules for labeling histidine-rich proteins
The invention provides Zn-chelating compounds that are molecularly engineered to bind to a specific target sequence in a protein of interest. The Zn2+ ion is far less toxic and promiscuous than nickel and therefore provides an attractive alternative to Ni...
08/23/2005
6703401Compounds, their preparation and use
The present invention relates to compounds of the general formula (I) ##STR1## The compounds are useful in the treatment and/or prevention of conditions mediated by clear receptors, in particular the Peroxisome Proliferator-Activated Receptors (PPAR)....
03/09/2004
6365586Compounds, their preparation and use
The present invention relates to compounds of the general formula (I) ##STR1## The compounds are useful in the treatment and/or prevention of conditions mediated by nuclear receptors, in particular the Peroxisome Proliferator-Activated Receptors (PPAR)....
04/02/2002
6270695Compounds, compositions, and methods for generating chemiluminescence with phosphatase enzymes
Novel heterocyclic compounds which generate chemiluminescence on reaction with a phosphatase enzyme are provided as well as a process for their preparation and intermediates useful therein. The compounds comprise a nitrogen, oxygen or sulfur-containing he...
08/07/2001
6159966Azolidinediones useful for the treatment of diabetes, dyslipidemia and hypertension: process for their preparation and pharmaceutical compositions containing them
A compound of formula (I) ##STR1## its tautomeric forms, its stereoisomers, its polymorphs, its pharmaceutically acceptable salts or its pharmaceutically acceptable solvates, wherein R3, R4, R5, and R6 are ...
12/12/2000
6117869Compounds for and methods of inhibiting matrix metalloproteinases
The present invention relates to compounds of Formula I that inhibit matrix metalloproteinases and to a method of inhibiting matrix metalloproteinases using the compounds ##STR1## More particularly, the present invention relates to a method of treati...
09/12/2000
5792389Water soluble laser dyes
Novel water soluble dyes of the formula I are provided ##STR1## wherein R1 and R4 are alkyl of 1 to 4 carbon atoms or hydrogen; or R1 -R2 or R2 -R4 form part of aliphatic heterocyclic ...
08/11/1998
5714606Pyrrolidine-containing monomers and oligomers
The invention relates to pyrrolidine monomeric units and to oligomers which are joined via phosphate linkages, including phosphorothioate, phosphodiester and phosphoramidate linkages....
02/03/1998
5656759Hydrophobic cationic dye compounds
When the counter ion of hydrophilic cationic dyes is substituted with an organic anion including a sulfosuffinate anion such as diethylhexylsulfonate anion, an alkylbenzenesulfonate anion such as a dodecylbenzenesulfonate, an alkylsulfate anion such as a ...
08/12/1997
5519134Pyrrolidine-containing monomers and oligomers
Novel pyrrolidine monomers bearing various functional groups are used to prepare oligomeric structures. The pyrrolidine monomers can be joined via standard phosphate linkages including phosphodiester and phosphorothioate linkages. Useful functional groups...
05/21/1996
5391482Method and diagnostic agent for enzyme substrate stabilization using 1-arylsemicarbazides
The present invention is concerned with the use of 1-arylsemicarbazides of the general formula: Ar--NH--NH--CON2 wherein Ar is an aryl radical optionally substituted by alkyl, alkoxy or halogen, for the stabilization of an enzyme substrate from whic...
02/21/1995
5319074Bifunctional reactive dyestuffs containing vinylsulphone or alkylsulphone groups and a 2,4 difluoro pyrimidine group
A metal-free dyestuff of the formula ##STR1## and metal complex thereof wherein: Fb=the radical of a dyestuff selected from the group consisting of mono- or polyazo, anthraquinone, phthalocyanine, formazan, dioxazine and triphenylmethane radicals, B ...
06/07/1994
5298607Reactive dyes containing fluorotriazine and vinylsulfonyl radicals
The invention provides reactive dyes of the formula ##STR1## wherein D is a mono- or polyazo, metal complex azo, anthraquinone, phthalocyanine, formazane, dioxazine or stilbene dye which contains sulfo groups, R1 is hydrogen or C1
03/29/1994
5246989Photochromic compound, composition and use thereof
A photochromic compound of the present invention is a spiroxazine compound represented by the following formula: ##STR1## wherein R1 to R3 represent a monovalent organic group such as alkyl group, Y represents a fused heterocycl...
09/21/1993
5238936Trisubstituted triazines
The compounds are trisubstituted triazines and pyrimidines useful for the suppressing the resistance of tumour cells to anti-cancer agents and for suppressing the resistance of parasites to anti-parasitic agents. A compound disclosed is 2,4-diallylamino-6...
08/24/1993
4954630Resorufin derivatives
The present invention provides resorufin derivatives of the general formulae: ##STR1## wherein R1, R2, R3, R4 and R5, which can be the same or different, are hydrogen, halogen, carboxyl, carboxam...
09/04/1990
4912258Fluorinated aniline derivatives and their use
Fluorinated aniline derivatives of the general formula I are described ##STR1## in which R1 represents H or (CH2)n -X, n is a whole number from 1 to 3, X is H, OH, NH2, CH3 CONH, CH3 SO
03/27/1990
4900822New hydrolase substrates
Reagents for the determination of hydrolase comprises compounds of the formula ##STR1## wherein Z is an organic or inorganic acid residue or a sugar residue, A is an organic or inorganic acid residue, and B is an organic acid residue. Each of R
02/13/1990
4861775Pharmacological use of phenoxazinones
Streptomyces spec. DSM 3813 produces novel compounds with a basic phenoxazinone structure, which have an antifungal and antiviral action and can be used as lipoxygenase inhibitors....
08/29/1989
4859667Pharmaceutical compositions of phenothiazone derivatives and analogs
Phenothiazone derivatives and analogs thereof, pharmaceutical compositions and methods of treatment are disclosed. These compounds are useful as inhibitors of mammalian leukotriene biosynthesis. As such, these compounds are useful therapeutic agents for t...
08/22/1989
4847376Lipase substrates
The present invention provides a lipase substrate of the general formula: ##STR1## wherein A is an alkylene or alkenylene radical containing up to 16 carbon atoms, R and R1, which can be the same or different, each signify an alkyl, alkeny...
07/11/1989
4837235Indole and indazole keto sulphones as leukotriene antagonists
This invention provides a series of novel keto sulfones of formula I ##STR1## in which the group .dbd.A-- is selected from .dbd.C(Ra)-- and .dbd.N-- and the other radicals have the meanings defined in the following specification. The compounds of for...
06/06/1989
48032694-monosubstituted and 4,6-disubstituted N-(଱-phenylethyl)phenoxazines
4-Monosubstituted and 4,6-disubstituted phenoxazines, methods of preparing them and pharmaceutical compositions containing them. These compounds are useful as anti-inflammatories....
02/07/1989
4741765Herbicidal sulfonamides
Benzenesulfonamide compounds such as N-[(4,6-dimethoxy-1,3,5-triazin-2-yl)aminocarbonyl]-1,4-dihydro-3-methyl-4 -oxo-1-phenyl-indeno[1,2-C]pyrazole-5-sulfonamide and N-[(4-methoxy-6-methyl-pyrimidin-2-yl)aminocarbonyl]-1,4-dihydro-3-methyl- 4-oxo-1-phe...
05/03/1988
4710570Azine redox dyes and leuco azine dyes
Azine redox dyes and their corresponding dyes of the formula: ##STR1## in which: X is O, S, NR2, Z completes a fused aromatic of heterocyclic ring system, n is 0 or 1 to allow one R1 ring substituent, Q represents CR4 R5
12/01/1987
47074734-monosubstituted and 4,6-disubstituted phenoxazines
4-Monosubstitued and 4,6-disubstituted phenoxazines, methods of preparing them and pharmaceutical compositions containing them. These compounds are useful as anti-inflammatories....
11/17/1987
4668671Tricyclic derivatives and pharmaceutical use
This invention describes tricyclic derivatives which are useful as histamine H1 -antagonists. A particular compound of this invention is 3-[3-(pyrido[3,2-b][1,4]-benzothiazin-10-yl)propylamino]-4-(pyrid-4-ylmeth ylamino)-1,2,5-thiadiazole-1-oxid...
05/26/1987
4667032Phenothiazone derivatives and analogs
Phenothiazone derivatives and analogs thereof, pharmaceutical compositions and methods of treatment are disclosed. These compounds are useful as inhibitors of mammalian leukotriene biosynthesis. As such, these compounds are useful therapeutic agents for t...
05/19/1987
4652646Thiazolo[3,2-a][1,2,3]triazolo[4,5-d]pyrimidine and [1,3,4]thiadiazolo[3,2-a][1,2,3]triazolo[4,5-d]pyrimidine derivatives
Novel triazolopyrimidine compounds represented by the formula (I) and physiologically acceptable salts thereof are disclosed. These compounds have an excellent anti-allergic activity in oral administration and are useful for treatment and prophylaxis of a...
03/24/1987
4366314Dimethine dyestuffs, their preparation and their use for dyeing synthetic and natural materials
Styryl dyestuffs of the general formula ##STR1## wherein Het represents a pyridinium radical having the structure ##STR2## R and R1 independently of one another designate lower alkyl or alkenyl groups, which can be substituted by non-...
12/28/1982
4305874Aniline azo dyes from 1,2,3,4-tetrahydroquinoline and 2,3-dihydro-1,4-benzoxazine couplers containing sulfate alkyl groups
Disclosed are novel dyes which comprise aniline diazo moieties and certain aromatic amine couplers having sulfate groups. These dyes are substantially water soluble and are particularly useful for dyeing polyamide, wool and the like and exhibit, for examp...
12/15/1981
4258182Quaternized amino-substituted styryl dyestuffs
Styryl dyestuffs of the formula ##STR1## wherein Q.sym. represents a grouping containing a quaternary nitrogen atom and A represents a bridge member, at least one of the radicals R and R1 denotes a carbocyclic or heterocyclic 5-membered or...
03/24/1981
4246404Basic indoline dyestuffs
Basic dyestuffs free of sulphonic acid groups contain an indoline group the 2-position of which is connected through a vinylene group to the N-atom of a 2,3-dihydro-4H-1,4-benzoxazine group. The dyestuffs are useful for the dyeing of leather, paper and pl...
01/20/1981
4131673N2 -arylsulfonyl-L-argininamides and the pharmaceutically acceptable salts thereof
N2 -arylsulfonyl-L-argininamides and the pharmaceutically acceptable salts thereof have been found to be effective as pharmaceutical agents for the inhibition and suppression of thrombosis in mammals....
12/26/1978
4117127N2 -Arylsulfonyl-L-argininamides and the pharmaceutically acceptable salts thereof
N2 -arylsulfonyl-L-argininamides and the pharmaceutically acceptable salts thereof have been found to be effective as pharmaceutical agents for the inhibition and suppression of thrombosis in mammals....
09/26/1978
4093712N2 -arylsulfonyl-L-argininamides and the pharmaceutically acceptable salts thereof
N2 -arylsulfonyl-L-argininamides and the pharmaceutically acceptable salts thereof have been found to be effective as pharmaceutical agents for the inhibition and suppression of thrombosis in mammals....
06/06/1978
4066773N2 -arylsulfonyl-L-argininamides and the pharmaceutically acceptable salts thereof
N2 -arylsulfonyl-L-argininamides and the pharmaceutically acceptable salts thereof have been found to be effective as pharmaceutical agents for the inhibition and suppression of thrombosis in mammals....
01/03/1978
1    
 
Sign InRegister
Username  
Password   
forgot password?